- Investing Ideas
- Swiss Pharmaceuticals & Biotech Blue chip stocks
Swiss Pharmaceuticals & Biotech Blue chip stocks
Results
3
0 new
3 companies
Lonza Group
Market Cap: CHF 34.5b
Operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.
LONN
CHF 491.60
7D
-0.08%
1Y
-11.9%
Galderma Group
Market Cap: CHF 40.5b
Operates as a dermatology company worldwide.
GALD
CHF 172.60
7D
2.4%
1Y
54.0%
Sandoz Group
Market Cap: CHF 29.8b
Develops, manufactures, and markets generic and biosimilars worldwide.
SDZ
CHF 67.68
7D
2.5%
1Y
55.2%